Phase 1b data on Lu AF28996, an investigational treatment for people with advanced Parkinson’s disease, to be presented at ...
EVE (NYSE:EVEX) highlighted progress on its eVTOL development program during its fourth quarter and full-year 2025 earnings call, emphasizing early flight-testing milestones, continued work with ...
NDMC has launched a round-the-clock water supply project in Chanakyapuri and beautification works at Bhairon Temple, costing ...
Reported positive Phase 2b RewinD-LB clinical data at CTAD 2025; additional analyses to be presented at AD/PD 2026 ...
Cognition Therapeutics, Inc., (the “Company” or “Cognition”) (NASDAQ: CGTX), a clinical-stage company developing drugs that treat neurodegenerative disorders, presented an analysis from the Phase 2 ...
China approves the world's first brain chip that helps paralyzed patients regain hand movement using brain-computer interface ...
Le Mans Ultimate Player Metrics -- Steam average concurrent players rose from about 786 in January to nearly 3,000 by ...
French developer Beyond Aero has dropped the electric ducted fans seen on previous iterations of its BYA-1 hydrogen fuel cell ...
We're looking at Trump's latest method for killing off EV charging, Uber's latest plans for robotaxis and more.
The Goa government plans to install AI-powered cameras at 92 locations across the state to strengthen traffic enforcement and improve road safety. Transport Minister Mauvin Godinho, replying to a ...
QUANZHOU CITY, FUJIAN PROVINCE, CHINA, March 17, 2026 /EINPresswire.com/ -- The global stone processing sector has ...
Morning Overview on MSN
Brazil paralysis therapy draws hope and hype as evidence remains limited
A Brazilian experimental therapy for spinal cord injury has generated intense public interest and legal battles, even as the scientific case for its use in humans rests almost entirely on animal data.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results